NasdaqGS:BCRXBiotechs
Assessing BioCryst Pharmaceuticals (BCRX) Valuation After Recent Share Price Rebound
What recent performance says about BioCryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals (BCRX) has been trading in a tight range, with the stock near US$7.45 after a gain of about 10% over the past week and month, yet a roughly 10% decline over the past year.
See our latest analysis for BioCryst Pharmaceuticals.
For BioCryst Pharmaceuticals, the recent 10.2% 7 day share price return and 9.7% 30 day share price return contrast with a 10.1% 1 year total shareholder return decline, which may...